Phospholine Iodide

— THERAPEUTIC CATEGORIES —
  • Glaucoma
  • Miscellaneous ocular agents

Phospholine Iodide Generic Name & Formulations

General Description

Ecothiophate iodide 0.125%; oph soln.

Pharmacological Class

Cholinesterase inhibitor.

How Supplied

Soln—5mL (w. diluent + dropper)

Manufacturer

Phospholine Iodide Indications

Indications

Reduction of elevated intraocular pressure (IOP).

Phospholine Iodide Dosage and Administration

Adult

1 drop twice daily, in the AM and at bedtime (1 drop once daily or every other day have been used). Apply finger pressure to inner canthus for 1–2mins after instillation.

Children

Not applicable.

Phospholine Iodide Contraindications

Contraindications

Active uveal inflammation. Angle-closure glaucoma without iridectomy.

Phospholine Iodide Boxed Warnings

Not Applicable

Phospholine Iodide Warnings/Precautions

Warnings/Precautions

Discontinue or withhold if cardiac irregularities, salivation, urinary incontinence, diarrhea, profuse sweating, muscle weakness, or respiratory difficulties occur. Vagotonia. Bronchial asthma. Spastic GI disturbances. Peptic ulcer. Pronounced bradycardia. Hypotension. Recent MI. Epilepsy. Parkinsonism. History of retinal detachment. Pregnancy. Nursing mothers: not recommended.

Phospholine Iodide Pharmacokinetics

See Literature

Phospholine Iodide Interactions

Interactions

Caution with other cholinesterase inhibitors (eg, succinylcholine, organophosphate and carbamate insecticides); additive effects.

Phospholine Iodide Adverse Reactions

Adverse Reactions

Stinging, burning, lacrimation, lid muscle twitching, conjunctival and ciliary redness, browache, induced myopia, visual blurring, activation of latent iritis, uveitis, iris cysts (esp. in children), conjunctival thickening, obstruction of nasolacrimal canals, lens opacities, retinal detachment, paradoxical increase in IOP, cardiac irregularities.

Phospholine Iodide Clinical Trials

See Literature

Phospholine Iodide Note

Not Applicable

Phospholine Iodide Patient Counseling

See Literature

Phospholine Iodide Generic Name & Formulations

General Description

Ecothiophate iodide 0.125%; oph soln.

Pharmacological Class

Cholinesterase inhibitor.

How Supplied

Soln—5mL (w. diluent + dropper)

Manufacturer

Phospholine Iodide Indications

Indications

Concomitant esotropias with a significant accommodative component.

Phospholine Iodide Dosage and Administration

Adult

Not applicable.

Children

Diagnosis: 1 drop once daily in both eyes at bedtime for a period of 2 or 3 weeks. Treatment: after diagnostic period, reduce to 1 drop once every other day; usual max: 1 drop once daily. Apply finger pressure to inner canthus for 1–2mins after instillation.

Phospholine Iodide Contraindications

Contraindications

Active uveal inflammation. Angle-closure glaucoma without iridectomy.

Phospholine Iodide Boxed Warnings

Not Applicable

Phospholine Iodide Warnings/Precautions

Warnings/Precautions

Discontinue or withhold if cardiac irregularities, salivation, urinary incontinence, diarrhea, profuse sweating, muscle weakness, or respiratory difficulties occur. Vagotonia. Bronchial asthma. Spastic GI disturbances. Peptic ulcer. Pronounced bradycardia. Hypotension. Recent MI. Epilepsy. Parkinsonism. History of retinal detachment. Pregnancy. Nursing mothers: not recommended.

Phospholine Iodide Pharmacokinetics

See Literature

Phospholine Iodide Interactions

Interactions

Caution with other cholinesterase inhibitors (eg, succinylcholine, organophosphate and carbamate insecticides); additive effects.

Phospholine Iodide Adverse Reactions

Adverse Reactions

Stinging, burning, lacrimation, lid muscle twitching, conjunctival and ciliary redness, browache, induced myopia, visual blurring, activation of latent iritis, uveitis, iris cysts (esp. in children), conjunctival thickening, obstruction of nasolacrimal canals, lens opacities, retinal detachment, paradoxical increase in IOP, cardiac irregularities.

Phospholine Iodide Clinical Trials

See Literature

Phospholine Iodide Note

Not Applicable

Phospholine Iodide Patient Counseling

See Literature